Key Segmentation:
By Product
-
Refractive Surgery Devices
-
Glaucoma Surgery Devices
-
Cataract Surgery Devices
-
Other Surgical Devices
By End User
-
Hospitals
-
Specialty Ophthalmic Clinics
-
Ambulatory Surgery Centers
-
Other End Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
Key opportunities include digital-OR and AI-powered surgical planning integration, expansion of low-cost phacoemulsification platforms in emerging markets, and continued growth of combination cataract-glaucoma procedures.
Key players include Alcon Inc., Johnson & Johnson Vision Care, Carl Zeiss Meditec AG, Bausch + Lomb Corp., and Glaukos Corp., which collectively controlled approximately 64.40% of global revenue in 2025, among others.
The primary growth factor is the global surge in cataract procedure volumes driven by aging demographics, combined with expanding surgical coverage under national vision-care and blindness-prevention initiatives.
By product, the Cataract Surgery Devices segment dominates the Ophthalmology Surgical Devices Market with approximately 41.02% share in 2025.
North America dominates the Ophthalmology Surgical Devices Market with approximately 31.75% share in 2025.